Hanall Pharm stock benefits from anti-atopic medication patent

Published: 2006-09-07 06:58:00
Updated: 2006-09-07 06:58:00
Shares of Hanall Pharm extended gains on expectations that its patent application of a novel anti-atopic drug will bring much profits in the long tem, analysts said on September 4.

Hanall closed 14.92 percent up at 18,350 won on September 4.

The company said it has filed a patent related to...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.